Premium
Letter: safe and effective cessation of long‐term nucleos(t)ide analogue therapy in noncirrhotic patients with HB eAg‐negative chronic hepatitis B
Author(s) -
Hadziyannis S. J.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13040
Subject(s) - medicine , discontinuation , hbeag , hepatitis b , clinical endpoint , gastroenterology , chronic hepatitis , immunology , hepatitis b virus , randomized controlled trial , hbsag , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom